Drug and Therapeutics Bulletin 1997;35:9-11; doi:10.1136/dtb.1997.3529
Copyright © 1997 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

Generic medicines - can quality be assured?

Generic prescribing is steadily increasing, a change which we¹ and others^2–4 encourage. The proportion of prescriptions written in general practice in England using the generic (approved) name increased from 35% in 1985 to 55% in 1995.⁵ Where a product is prescribed generically, the alternatives that could be supplied should be equivalent, to ensure that patients are not put at risk. In this article, we review how the equivalence and quality of generic drugs are assured and consider whether the process is adequate.

This article has been cited by other articles:

				A. S. Kesselheim, A. S. Misono, J. L. Lee, M. R. Stedman, M. A. Brookhart, N. K. Choudhry, and W. H. Shrank Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular Disease: A Systematic Review and Meta-analysis JAMA, December 3, 2008; 300(21): 2514 - 2526. [Abstract] [Full Text] [PDF]